Global Rofecoxib Market Research Report 2025(Status and Outlook)
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
This report offers a comprehensive and in-depth analysis of the global Rofecoxib market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rofecoxib market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rofecoxib market.
Global Rofecoxib Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Market Segmentation (by Type)
Oral Suspension.
Tablet-Form
Market Segmentation (by Application)
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rofecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rofecoxib, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Rofecoxib market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rofecoxib market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rofecoxib market.
Global Rofecoxib Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Market Segmentation (by Type)
Oral Suspension.
Tablet-Form
Market Segmentation (by Application)
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Rofecoxib Market
- Overview of the regional outlook of the Rofecoxib Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rofecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rofecoxib, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Rofecoxib
1.2 Key Market Segments
1.2.1 Rofecoxib Segment by Type
1.2.2 Rofecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ROFECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rofecoxib Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Rofecoxib Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ROFECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rofecoxib Product Life Cycle
3.3 Global Rofecoxib Sales by Manufacturers (2020-2025)
3.4 Global Rofecoxib Revenue Market Share by Manufacturers (2020-2025)
3.5 Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rofecoxib Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Rofecoxib Market Competitive Situation and Trends
3.8.1 Rofecoxib Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rofecoxib Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ROFECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Rofecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ROFECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rofecoxib Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rofecoxib Market
5.7 ESG Ratings of Leading Companies
6 ROFECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rofecoxib Sales Market Share by Type (2020-2025)
6.3 Global Rofecoxib Market Size Market Share by Type (2020-2025)
6.4 Global Rofecoxib Price by Type (2020-2025)
7 ROFECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rofecoxib Market Sales by Application (2020-2025)
7.3 Global Rofecoxib Market Size (M USD) by Application (2020-2025)
7.4 Global Rofecoxib Sales Growth Rate by Application (2020-2025)
8 ROFECOXIB MARKET SALES BY REGION
8.1 Global Rofecoxib Sales by Region
8.1.1 Global Rofecoxib Sales by Region
8.1.2 Global Rofecoxib Sales Market Share by Region
8.2 Global Rofecoxib Market Size by Region
8.2.1 Global Rofecoxib Market Size by Region
8.2.2 Global Rofecoxib Market Size Market Share by Region
8.3 North America
8.3.1 North America Rofecoxib Sales by Country
8.3.2 North America Rofecoxib Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rofecoxib Sales by Country
8.4.2 Europe Rofecoxib Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rofecoxib Sales by Region
8.5.2 Asia Pacific Rofecoxib Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rofecoxib Sales by Country
8.6.2 South America Rofecoxib Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rofecoxib Sales by Region
8.7.2 Middle East and Africa Rofecoxib Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ROFECOXIB MARKET PRODUCTION BY REGION
9.1 Global Production of Rofecoxib by Region(2020-2025)
9.2 Global Rofecoxib Revenue Market Share by Region (2020-2025)
9.3 Global Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rofecoxib Production
9.4.1 North America Rofecoxib Production Growth Rate (2020-2025)
9.4.2 North America Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rofecoxib Production
9.5.1 Europe Rofecoxib Production Growth Rate (2020-2025)
9.5.2 Europe Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rofecoxib Production (2020-2025)
9.6.1 Japan Rofecoxib Production Growth Rate (2020-2025)
9.6.2 Japan Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rofecoxib Production (2020-2025)
9.7.1 China Rofecoxib Production Growth Rate (2020-2025)
9.7.2 China Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Rofecoxib Product Overview
10.1.3 Merck Rofecoxib Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Chengdu Meinkai Chemical Co. LTD
10.2.1 Chengdu Meinkai Chemical Co. LTD Basic Information
10.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Overview
10.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Market Performance
10.2.4 Chengdu Meinkai Chemical Co. LTD Business Overview
10.2.5 Chengdu Meinkai Chemical Co. LTD SWOT Analysis
10.2.6 Chengdu Meinkai Chemical Co. LTD Recent Developments
10.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
10.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information
10.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Overview
10.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Market Performance
10.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
10.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD SWOT Analysis
10.3.6 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
10.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
10.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information
10.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Overview
10.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Market Performance
10.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
10.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
10.5 Pfizer
10.5.1 Pfizer Basic Information
10.5.2 Pfizer Rofecoxib Product Overview
10.5.3 Pfizer Rofecoxib Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Tremeau
10.6.1 Tremeau Basic Information
10.6.2 Tremeau Rofecoxib Product Overview
10.6.3 Tremeau Rofecoxib Product Market Performance
10.6.4 Tremeau Business Overview
10.6.5 Tremeau Recent Developments
11 ROFECOXIB MARKET FORECAST BY REGION
11.1 Global Rofecoxib Market Size Forecast
11.2 Global Rofecoxib Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rofecoxib Market Size Forecast by Country
11.2.3 Asia Pacific Rofecoxib Market Size Forecast by Region
11.2.4 South America Rofecoxib Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rofecoxib by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Rofecoxib Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Rofecoxib by Type (2026-2033)
12.1.2 Global Rofecoxib Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Rofecoxib by Type (2026-2033)
12.2 Global Rofecoxib Market Forecast by Application (2026-2033)
12.2.1 Global Rofecoxib Sales (K MT) Forecast by Application
12.2.2 Global Rofecoxib Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Rofecoxib
1.2 Key Market Segments
1.2.1 Rofecoxib Segment by Type
1.2.2 Rofecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ROFECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rofecoxib Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Rofecoxib Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ROFECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rofecoxib Product Life Cycle
3.3 Global Rofecoxib Sales by Manufacturers (2020-2025)
3.4 Global Rofecoxib Revenue Market Share by Manufacturers (2020-2025)
3.5 Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rofecoxib Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Rofecoxib Market Competitive Situation and Trends
3.8.1 Rofecoxib Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rofecoxib Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ROFECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Rofecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ROFECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rofecoxib Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rofecoxib Market
5.7 ESG Ratings of Leading Companies
6 ROFECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rofecoxib Sales Market Share by Type (2020-2025)
6.3 Global Rofecoxib Market Size Market Share by Type (2020-2025)
6.4 Global Rofecoxib Price by Type (2020-2025)
7 ROFECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rofecoxib Market Sales by Application (2020-2025)
7.3 Global Rofecoxib Market Size (M USD) by Application (2020-2025)
7.4 Global Rofecoxib Sales Growth Rate by Application (2020-2025)
8 ROFECOXIB MARKET SALES BY REGION
8.1 Global Rofecoxib Sales by Region
8.1.1 Global Rofecoxib Sales by Region
8.1.2 Global Rofecoxib Sales Market Share by Region
8.2 Global Rofecoxib Market Size by Region
8.2.1 Global Rofecoxib Market Size by Region
8.2.2 Global Rofecoxib Market Size Market Share by Region
8.3 North America
8.3.1 North America Rofecoxib Sales by Country
8.3.2 North America Rofecoxib Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rofecoxib Sales by Country
8.4.2 Europe Rofecoxib Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rofecoxib Sales by Region
8.5.2 Asia Pacific Rofecoxib Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rofecoxib Sales by Country
8.6.2 South America Rofecoxib Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rofecoxib Sales by Region
8.7.2 Middle East and Africa Rofecoxib Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ROFECOXIB MARKET PRODUCTION BY REGION
9.1 Global Production of Rofecoxib by Region(2020-2025)
9.2 Global Rofecoxib Revenue Market Share by Region (2020-2025)
9.3 Global Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rofecoxib Production
9.4.1 North America Rofecoxib Production Growth Rate (2020-2025)
9.4.2 North America Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rofecoxib Production
9.5.1 Europe Rofecoxib Production Growth Rate (2020-2025)
9.5.2 Europe Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rofecoxib Production (2020-2025)
9.6.1 Japan Rofecoxib Production Growth Rate (2020-2025)
9.6.2 Japan Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rofecoxib Production (2020-2025)
9.7.1 China Rofecoxib Production Growth Rate (2020-2025)
9.7.2 China Rofecoxib Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Rofecoxib Product Overview
10.1.3 Merck Rofecoxib Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Chengdu Meinkai Chemical Co. LTD
10.2.1 Chengdu Meinkai Chemical Co. LTD Basic Information
10.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Overview
10.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Market Performance
10.2.4 Chengdu Meinkai Chemical Co. LTD Business Overview
10.2.5 Chengdu Meinkai Chemical Co. LTD SWOT Analysis
10.2.6 Chengdu Meinkai Chemical Co. LTD Recent Developments
10.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
10.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information
10.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Overview
10.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Market Performance
10.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
10.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD SWOT Analysis
10.3.6 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
10.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
10.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information
10.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Overview
10.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Market Performance
10.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
10.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
10.5 Pfizer
10.5.1 Pfizer Basic Information
10.5.2 Pfizer Rofecoxib Product Overview
10.5.3 Pfizer Rofecoxib Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Tremeau
10.6.1 Tremeau Basic Information
10.6.2 Tremeau Rofecoxib Product Overview
10.6.3 Tremeau Rofecoxib Product Market Performance
10.6.4 Tremeau Business Overview
10.6.5 Tremeau Recent Developments
11 ROFECOXIB MARKET FORECAST BY REGION
11.1 Global Rofecoxib Market Size Forecast
11.2 Global Rofecoxib Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rofecoxib Market Size Forecast by Country
11.2.3 Asia Pacific Rofecoxib Market Size Forecast by Region
11.2.4 South America Rofecoxib Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rofecoxib by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Rofecoxib Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Rofecoxib by Type (2026-2033)
12.1.2 Global Rofecoxib Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Rofecoxib by Type (2026-2033)
12.2 Global Rofecoxib Market Forecast by Application (2026-2033)
12.2.1 Global Rofecoxib Sales (K MT) Forecast by Application
12.2.2 Global Rofecoxib Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rofecoxib Market Size Comparison by Region (M USD)
Table 5. Global Rofecoxib Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Rofecoxib Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Rofecoxib Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Rofecoxib Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rofecoxib as of 2024)
Table 10. Global Market Rofecoxib Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Rofecoxib Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Rofecoxib Sales by Type (K MT)
Table 26. Global Rofecoxib Market Size by Type (M USD)
Table 27. Global Rofecoxib Sales (K MT) by Type (2020-2025)
Table 28. Global Rofecoxib Sales Market Share by Type (2020-2025)
Table 29. Global Rofecoxib Market Size (M USD) by Type (2020-2025)
Table 30. Global Rofecoxib Market Size Share by Type (2020-2025)
Table 31. Global Rofecoxib Price (USD/KG) by Type (2020-2025)
Table 32. Global Rofecoxib Sales (K MT) by Application
Table 33. Global Rofecoxib Market Size by Application
Table 34. Global Rofecoxib Sales by Application (2020-2025) & (K MT)
Table 35. Global Rofecoxib Sales Market Share by Application (2020-2025)
Table 36. Global Rofecoxib Market Size by Application (2020-2025) & (M USD)
Table 37. Global Rofecoxib Market Share by Application (2020-2025)
Table 38. Global Rofecoxib Sales Growth Rate by Application (2020-2025)
Table 39. Global Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 40. Global Rofecoxib Sales Market Share by Region (2020-2025)
Table 41. Global Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 42. Global Rofecoxib Market Size Market Share by Region (2020-2025)
Table 43. North America Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 44. North America Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 46. Europe Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 49. South America Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 50. South America Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 53. Global Rofecoxib Production (K MT) by Region(2020-2025)
Table 54. Global Rofecoxib Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Rofecoxib Revenue Market Share by Region (2020-2025)
Table 56. Global Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Rofecoxib Product Overview
Table 63. Merck Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Chengdu Meinkai Chemical Co. LTD Basic Information
Table 68. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Overview
Table 69. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Chengdu Meinkai Chemical Co. LTD Business Overview
Table 71. Chengdu Meinkai Chemical Co. LTD SWOT Analysis
Table 72. Chengdu Meinkai Chemical Co. LTD Recent Developments
Table 73. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information
Table 74. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Overview
Table 75. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
Table 77. Wuhan Xinxin Jiali Biotechnology Co. LTD SWOT Analysis
Table 78. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
Table 79. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information
Table 80. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Overview
Table 81. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
Table 83. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
Table 84. Pfizer Basic Information
Table 85. Pfizer Rofecoxib Product Overview
Table 86. Pfizer Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Tremeau Basic Information
Table 90. Tremeau Rofecoxib Product Overview
Table 91. Tremeau Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Tremeau Business Overview
Table 93. Tremeau Recent Developments
Table 94. Global Rofecoxib Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Rofecoxib Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Rofecoxib Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Rofecoxib Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Rofecoxib Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Rofecoxib Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Rofecoxib Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Rofecoxib Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Rofecoxib Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Rofecoxib Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rofecoxib Market Size Comparison by Region (M USD)
Table 5. Global Rofecoxib Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Rofecoxib Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Rofecoxib Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Rofecoxib Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rofecoxib as of 2024)
Table 10. Global Market Rofecoxib Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Rofecoxib Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Rofecoxib Sales by Type (K MT)
Table 26. Global Rofecoxib Market Size by Type (M USD)
Table 27. Global Rofecoxib Sales (K MT) by Type (2020-2025)
Table 28. Global Rofecoxib Sales Market Share by Type (2020-2025)
Table 29. Global Rofecoxib Market Size (M USD) by Type (2020-2025)
Table 30. Global Rofecoxib Market Size Share by Type (2020-2025)
Table 31. Global Rofecoxib Price (USD/KG) by Type (2020-2025)
Table 32. Global Rofecoxib Sales (K MT) by Application
Table 33. Global Rofecoxib Market Size by Application
Table 34. Global Rofecoxib Sales by Application (2020-2025) & (K MT)
Table 35. Global Rofecoxib Sales Market Share by Application (2020-2025)
Table 36. Global Rofecoxib Market Size by Application (2020-2025) & (M USD)
Table 37. Global Rofecoxib Market Share by Application (2020-2025)
Table 38. Global Rofecoxib Sales Growth Rate by Application (2020-2025)
Table 39. Global Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 40. Global Rofecoxib Sales Market Share by Region (2020-2025)
Table 41. Global Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 42. Global Rofecoxib Market Size Market Share by Region (2020-2025)
Table 43. North America Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 44. North America Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 46. Europe Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 49. South America Rofecoxib Sales by Country (2020-2025) & (K MT)
Table 50. South America Rofecoxib Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Rofecoxib Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Rofecoxib Market Size by Region (2020-2025) & (M USD)
Table 53. Global Rofecoxib Production (K MT) by Region(2020-2025)
Table 54. Global Rofecoxib Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Rofecoxib Revenue Market Share by Region (2020-2025)
Table 56. Global Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Rofecoxib Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Rofecoxib Product Overview
Table 63. Merck Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Chengdu Meinkai Chemical Co. LTD Basic Information
Table 68. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Overview
Table 69. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Chengdu Meinkai Chemical Co. LTD Business Overview
Table 71. Chengdu Meinkai Chemical Co. LTD SWOT Analysis
Table 72. Chengdu Meinkai Chemical Co. LTD Recent Developments
Table 73. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information
Table 74. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Overview
Table 75. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
Table 77. Wuhan Xinxin Jiali Biotechnology Co. LTD SWOT Analysis
Table 78. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
Table 79. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information
Table 80. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Overview
Table 81. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
Table 83. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
Table 84. Pfizer Basic Information
Table 85. Pfizer Rofecoxib Product Overview
Table 86. Pfizer Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Tremeau Basic Information
Table 90. Tremeau Rofecoxib Product Overview
Table 91. Tremeau Rofecoxib Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Tremeau Business Overview
Table 93. Tremeau Recent Developments
Table 94. Global Rofecoxib Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Rofecoxib Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Rofecoxib Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Rofecoxib Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Rofecoxib Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Rofecoxib Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Rofecoxib Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Rofecoxib Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Rofecoxib Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Rofecoxib Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Rofecoxib Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Rofecoxib Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Rofecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rofecoxib Market Size (M USD), 2024-2033
Figure 5. Global Rofecoxib Market Size (M USD) (2020-2033)
Figure 6. Global Rofecoxib Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rofecoxib Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rofecoxib Product Life Cycle
Figure 13. Rofecoxib Sales Share by Manufacturers in 2024
Figure 14. Global Rofecoxib Revenue Share by Manufacturers in 2024
Figure 15. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Rofecoxib Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rofecoxib Revenue in 2024
Figure 18. Industry Chain Map of Rofecoxib
Figure 19. Global Rofecoxib Market PEST Analysis
Figure 20. Global Rofecoxib Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rofecoxib Market Share by Type
Figure 27. Sales Market Share of Rofecoxib by Type (2020-2025)
Figure 28. Sales Market Share of Rofecoxib by Type in 2024
Figure 29. Market Size Share of Rofecoxib by Type (2020-2025)
Figure 30. Market Size Share of Rofecoxib by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rofecoxib Market Share by Application
Figure 33. Global Rofecoxib Sales Market Share by Application (2020-2025)
Figure 34. Global Rofecoxib Sales Market Share by Application in 2024
Figure 35. Global Rofecoxib Market Share by Application (2020-2025)
Figure 36. Global Rofecoxib Market Share by Application in 2024
Figure 37. Global Rofecoxib Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rofecoxib Sales Market Share by Region (2020-2025)
Figure 39. Global Rofecoxib Market Size Market Share by Region (2020-2025)
Figure 40. North America Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Rofecoxib Sales Market Share by Country in 2024
Figure 43. North America Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rofecoxib Market Size Market Share by Country in 2024
Figure 45. U.S. Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rofecoxib Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Rofecoxib Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rofecoxib Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rofecoxib Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Rofecoxib Sales Market Share by Country in 2024
Figure 53. Europe Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rofecoxib Market Size Market Share by Country in 2024
Figure 55. Germany Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rofecoxib Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Rofecoxib Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rofecoxib Market Size Market Share by Region in 2024
Figure 68. China Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rofecoxib Sales and Growth Rate (K MT)
Figure 79. South America Rofecoxib Sales Market Share by Country in 2024
Figure 80. South America Rofecoxib Market Size and Growth Rate (M USD)
Figure 81. South America Rofecoxib Market Size Market Share by Country in 2024
Figure 82. Brazil Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rofecoxib Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Rofecoxib Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rofecoxib Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rofecoxib Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rofecoxib Production Market Share by Region (2020-2025)
Figure 103. North America Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 106. China Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Rofecoxib Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Rofecoxib Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Rofecoxib Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Rofecoxib Market Share Forecast by Type (2026-2033)
Figure 111. Global Rofecoxib Sales Forecast by Application (2026-2033)
Figure 112. Global Rofecoxib Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Rofecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rofecoxib Market Size (M USD), 2024-2033
Figure 5. Global Rofecoxib Market Size (M USD) (2020-2033)
Figure 6. Global Rofecoxib Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rofecoxib Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rofecoxib Product Life Cycle
Figure 13. Rofecoxib Sales Share by Manufacturers in 2024
Figure 14. Global Rofecoxib Revenue Share by Manufacturers in 2024
Figure 15. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Rofecoxib Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rofecoxib Revenue in 2024
Figure 18. Industry Chain Map of Rofecoxib
Figure 19. Global Rofecoxib Market PEST Analysis
Figure 20. Global Rofecoxib Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rofecoxib Market Share by Type
Figure 27. Sales Market Share of Rofecoxib by Type (2020-2025)
Figure 28. Sales Market Share of Rofecoxib by Type in 2024
Figure 29. Market Size Share of Rofecoxib by Type (2020-2025)
Figure 30. Market Size Share of Rofecoxib by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rofecoxib Market Share by Application
Figure 33. Global Rofecoxib Sales Market Share by Application (2020-2025)
Figure 34. Global Rofecoxib Sales Market Share by Application in 2024
Figure 35. Global Rofecoxib Market Share by Application (2020-2025)
Figure 36. Global Rofecoxib Market Share by Application in 2024
Figure 37. Global Rofecoxib Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rofecoxib Sales Market Share by Region (2020-2025)
Figure 39. Global Rofecoxib Market Size Market Share by Region (2020-2025)
Figure 40. North America Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Rofecoxib Sales Market Share by Country in 2024
Figure 43. North America Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rofecoxib Market Size Market Share by Country in 2024
Figure 45. U.S. Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rofecoxib Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Rofecoxib Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rofecoxib Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rofecoxib Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Rofecoxib Sales Market Share by Country in 2024
Figure 53. Europe Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rofecoxib Market Size Market Share by Country in 2024
Figure 55. Germany Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rofecoxib Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Rofecoxib Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rofecoxib Market Size Market Share by Region in 2024
Figure 68. China Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rofecoxib Sales and Growth Rate (K MT)
Figure 79. South America Rofecoxib Sales Market Share by Country in 2024
Figure 80. South America Rofecoxib Market Size and Growth Rate (M USD)
Figure 81. South America Rofecoxib Market Size Market Share by Country in 2024
Figure 82. Brazil Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rofecoxib Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Rofecoxib Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rofecoxib Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rofecoxib Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rofecoxib Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Rofecoxib Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rofecoxib Production Market Share by Region (2020-2025)
Figure 103. North America Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 106. China Rofecoxib Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Rofecoxib Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Rofecoxib Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Rofecoxib Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Rofecoxib Market Share Forecast by Type (2026-2033)
Figure 111. Global Rofecoxib Sales Forecast by Application (2026-2033)
Figure 112. Global Rofecoxib Market Share Forecast by Application (2026-2033)
